SCHEMBL59883

SCHEMBL59883

OB(O)c1ccc(F)c(F)c1F

nearest known ligand 0.48

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.41
CES1 P23141 3/20 0.41
DAO P14920 1/20 0.31
LPL P06858 1/20 0.31
LIPG Q9Y5X9 1/20 0.31
NPC1 O15118 1/20 0.31
BCHE P06276 1/20 0.30
ENPP2 Q13822 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29465762 1.00 CES2 (0.41) CES2CES1DAOLPLLIPG
Methyl Alcohol SCHEMBL29194951 0.97 CES2 (0.39) CES2CES1DAOLPLLIPG
SCHEMBL29219393 0.97 CES2 (0.39) CES2CES1DAOLPLLIPG
Alcohol SCHEMBL29195001 0.91 LPL (0.35) CES2CES1LPLLIPGENPP2
SCHEMBL9562009 0.89 LPL (0.35) LPLLIPGENPP2
SCHEMBL8170579 0.84 CES2 (0.31) CES2CES1LPLLIPGENPP2
SCHEMBL18287667 0.80 CA2 (0.32) DAOLPLLIPG
SCHEMBL26923729 0.80 ERN1 (0.39)
SCHEMBL29465765 0.80 CA2 (0.32) DAOLPLLIPG
SCHEMBL20592892 0.80 ERN1 (0.34) CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 482 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010979-A Organic micromolecular photovoltaic material based on benzopyrazine donor cores, and preparation method and application thereof 国家纳米科学中心 2026-05-12 CN claimed
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
CN-118852609-B Production process of aqueous polyamide wax rheological additive 安徽协合新材料有限公司 2024-12-27 CN claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11793220-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-10-24 US claimed
CN-116916755-A Materials and methods for extending the shelf life of food products JP实验室公司 2023-10-20 CN claimed
US-20230323029-A1 POLYMERS BASED ON IONIC MONOMERS, COMPOSITIONS COMPRISING SAME, METHODS FOR MANUFACTURING SAME, AND USE THEREOF IN ELECTROCHEMICAL APPLICATIONS HYDRO-QUéBEC (CA) 2023-10-12 US claimed
WO-2022159439-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2022-07-28 WO claimed
US-20220225647-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
US-20220225646-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
WO-2021146815-A1 POLYMERS BASED ON IONIC MONOMERS, COMPOSITIONS COMPRISING SAME, METHODS FOR MANUFACTURING SAME, AND USE THEREOF IN ELECTROCHEMICAL APPLICATIONS HYDRO-QUéBEC (CA) 2021-07-29 WO claimed
EP-3854835-A1 POLYMER COMPOSITIONS COMPRISING AT LEAST ONE POLYMER BASED ON IONIC MONOMERS, METHODS OF MAKING SAME AND THEIR USE IN ELECTROCHEMICAL APPLICATIONS HYDRO-QUEBEC (CA) 2021-07-28 EP claimed
CN-107663257-B Catalyst composition for long-chain alpha-olefin polymerization and method for catalyzing long-chain alpha-olefin polymerization by using catalyst composition 中国石油化工股份有限公司 2020-09-15 CN claimed
US-8361484-B2 Polymer systems for lung volume reduction therapy AERIS THERAPEUTICS, INC. (US) 2013-01-29 US claimed
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy CANADIAN IMPERIAL BANK OF COMMERCE (CA) 2010-02-18 US claimed
EP-2059227-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY Aeris Therapeutics, Inc. (US) 2009-05-20 EP claimed
WO-2008039827-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY AERIS THERAPEUTICS, INC. (US) 2008-04-03 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy GFER, MUC1, CTH CES2 1317/4885CES1 1971/4885DAO 2098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.